Us Bancorp \De\ Recursion Pharmaceuticals, Inc. Transaction History
Us Bancorp \De\
- $78.3 Billion
- Q2 2025
A detailed history of Us Bancorp \De\ transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 22,173 shares of RXRX stock, worth $119,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,173
Previous 1,871
1085.09%
Holding current value
$119,955
Previous $9,000
1144.44%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RXRX
# of Institutions
357Shares Held
293MCall Options Held
3.28MPut Options Held
3.24M-
Vanguard Group Inc Valley Forge, PA36.1MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$178 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$131 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$93.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$79.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $976M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...